SANUWAVE Announces DFU Joint Investigational Partnership with HyperMed
July 11, 2018 13:20 ET
|
SANUWAVE Health, Inc.
SUWANEE, GA, July 11, 2018 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB: SNWV) is pleased to announce a partnership with HyperMed in Memphis, TN to sponsor a continuing clinical investigation on...
SANUWAVE Announces First Shipments of the dermaPACE System in the U.S. Market
March 02, 2018 09:00 ET
|
SANUWAVE Health, Inc.
SUWANEE, GA, March 02, 2018 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCQB: SNWV) is pleased to announce that the first product shipments in the U.S. market of the company’s dermaPACE®System...
Origin™ Announces First 50 Patients Randomized, and Full Site Activation in Phase IIb Dose-Ranging Study for Diabetic Foot Ulcers
June 01, 2017 08:30 ET
|
Origin
PRINCETON, N.J., June 01, 2017 (GLOBE NEWSWIRE) -- Origin, Inc. (formerly Advanced Plasma Therapies, Inc), a Princeton, NJ based clinical-stage wound care company focused on treatment of Diabetic...
Integra LifeSciences Announces the European Launch of Integra® Dermal Regeneration Template Single Layer “Thin”
May 17, 2017 02:00 ET
|
Integra LifeSciences Holdings Corporation
PLAINSBORO, N.J., May 17, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company, today announced that it has launched in...